Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Current Assets (2020 - 2025)

Oncology Institute's Current Assets history spans 6 years, with the latest figure at $112.7 million for Q4 2025.

  • For Q4 2025, Current Assets changed 0.29% year-over-year to $112.7 million; the TTM value through Dec 2025 reached $112.7 million, changed 0.29%, while the annual FY2025 figure was $112.7 million, 0.29% changed from the prior year.
  • Current Assets reached $112.7 million in Q4 2025 per TOI's latest filing, up from $110.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $154.1 million in Q4 2021 to a low of $287110.0 in Q3 2021.
  • Average Current Assets over 5 years is $106.1 million, with a median of $114.5 million recorded in 2024.
  • Peak YoY movement for Current Assets: crashed 76.09% in 2021, then soared 49926.47% in 2022.
  • A 5-year view of Current Assets shows it stood at $154.1 million in 2021, then fell by 15.34% to $130.4 million in 2022, then rose by 10.03% to $143.5 million in 2023, then dropped by 21.66% to $112.4 million in 2024, then grew by 0.29% to $112.7 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Current Assets are $112.7 million (Q4 2025), $110.1 million (Q3 2025), and $104.8 million (Q2 2025).